close

Login

Library
Shopping Cart
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 
Direct (781) 489-7301,  Toll Free (866) 285-7215

Search

Search
BCC Advance Search

Global Markets and Technologies for Pandemic Control

  • Published: March 2013
  • |
  • Report Code: PHM042B

REPORT HIGHLIGHTS

The total market for pandemic infectious disease products broken down by disease type was $31.6 billion in 2011 and $35.6 billion in 2012. The market is expected to rise at a CAGR of 9.3% and reach nearly $55.6 billion by 2017.

The report provides:

  • An overview of the products in development to treat bacterial diseases, especially those caused by drug-resistant organisms, and HIV/AIDS
  • Analyses of market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Clarification of the HIV/AIDS pandemic and ongoing efforts to control it
  • Discussion of emerging threats, such as multidrug-resistant tuberculosis, West Nile virus and other serious viral diseases
  • Trends based on projected sales through 2017 for new products, including supporting analyses for projections.
  • Comprehensive company profiles of major players.

SAMPLE FIGURE
PROJECTED MARKET FOR PANDEMIC INFECTIOUS DISEASE PRODUCTS, BY REGION, 2012 AND 2017
(%)
PROJECTED MARKET FOR PANDEMIC INFECTIOUS DISEASE PRODUCTS, BY REGION, 2012 AND 2017
To Contact us, click here  help


Source: BCC Research

Download Report Overview

REPORT SCOPE

SCOPE OF REPORT

This report provides an in-depth look at the emerging pandemic of antibiotic resistance and the established viral pandemic of HIV/AIDS. It also provides historical, epidemiological and market information on hepatitis B and C, tuberculosis and malaria. This report also investigates bacterial and viral diseases that are emerging as health threats because of inadequate or nonexistent preventive and/or therapeutic products to combat them.

Antibiotic-resistant organisms wreak havoc with international healthcare systems as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE) and Clostridium difficile (C. diffile) become more pervasive. These infections represent future pandemics if no suitable antibiotics are developed to counteract them. At present, each is problematic, but remains at an epidemic level, primarily within healthcare institutions and nursing facilities. Consequently, these infections are covered descriptively within the report, but are not yet classified as pandemics, nor measured quantitatively as part of the overall market for pandemics.

The report outlines the available preventative and diagnostic products used to combat current and future pandemic infections and projects markets for these products. Forecasts are provided for the diagnostic and pharmaceutical markets for products to treat HIV/AIDS, hepatitis B and C, malaria and tuberculosis. Forecasts and trends are gleaned from industry sources as well as from an assessment of emerging products and technologies.

The causes, the extent of impact and strategies to monitor, treat and prevent resistant diseases are assessed. The mechanisms by which drugs function to combat resistant microbes are described. Drugs that show promise of long-term activity (i.e., low likelihood of resistance) and their effects on the market are assessed.

ANALYST CREDENTIALS

Peggy S. Lehr is the BCC Research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and a MS in Communication from the University of Denver. Ms. Lehr has worked as a researcher, editor and publisher within the publishing industry for both for-profit and not-for-profit organizations.


Download Report Overview

REPORT TOC

download table of contents
Pricing on the website is provided for single users and 2-5 users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at (+1)781-489-7301 or send an email to information@bccresearch.com
  Title/Chapter Name Pages Price
Global Markets and Technologies for Pandemic Control 172 $6650
Chapter- 1: INTRODUCTION - Complimentary 3 $0
  Show Details
Chapter- 2: SUMMARY 3 $250
  Show Details
Chapter- 3: OVERVIEW 16 $928
  Show Details
Chapter- 4: VACCINES, DIAGNOSTIC TESTING, AND PHARMACEUTICAL MARKETS FOR INFECTIOUS DISEASES 27 $1566
  Show Details
Chapter- 5: DISEASE OVERVIEW 24 $1392
  Show Details
Chapter- 6: VIRAL PANDEMIC THREATS AND TREATMENTS 21 $1218
  Show Details
Chapter- 7: BACTERIAL PANDEMIC THREATS AND TREATMENTS 17 $986
  Show Details
Chapter- 8: PARASITIC PANDEMIC THREATS AND TREATMENTS 11 $638
  Show Details
Chapter- 9: REGULATIONS 5 $290
  Show Details
Chapter- 10: PHARMACEUTICAL TREATMENT PIPELINE 10 $580
  Show Details
Chapter- 11: PATENT ANALYSIS 11 $638
  Show Details
Chapter- 12: COMPANY DIRECTORY 24 $1392
  Show Details
 
  List of Tables
  List of Figures
Recommended combos for Forecast Model
+

BCC Research Report

Price: $6650

=

Total Price: $11650

Combo Price: $8000

Discount will be applied automatically after you will add the forecast model and any report to your cart.

 
Select License type:
buy now
download report overview
Want to find out more
about this report?
request more info
Get Notified
on all the latest research reports
Subscribe

Choose your License

loading animation for AJAX calls